WESTLAKE VILLAGE, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage ...
UBS forecasts that Sandoz will likely achieve the lower end of its 24-26% core EBITDA margin target by 2028. To reach the higher end, Sandoz would need substantial cost cuts or increased profits from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback